by This represents a major breakthrough compared to traditional short read sequencing technologies that were limited to reads of only a few hundred bases. The ability to generate such long reads enables researchers to solve problems that were previously intractable with short read data. Some of the key advantages and applications of long read sequencing include:
Resolving repetitive regions of genomes
One of the biggest challenges with short read sequencing is accurately assembling regions of genomes that contain repeats, duplications or copy number variations. Long Read Sequencing Short reads are simply too short to unambiguously place repeats within genomes, leading to gaps or misassemblies. In contrast, long reads can easily span repetitive elements, allowing researchers to generate essentially gap-free assemblies of even the most complex genomes. This has revolutionized our ability to assemble entire human genomes as well as explore complex disease-associated structural variations.
Isoform sequencing of transcriptomes
Nearly all human genes undergo alternative splicing to generate multiple mRNA isoforms and protein variants from a single gene. However, short read sequencing cannot distinguish individual isoforms or conclusively map splicing junctions. Long reads that span entire transcripts and mRNA isoforms have opened up the field of full-length isoform discovery and quantification. Scientists are gaining unprecedented insight into tissue-specific splicing programs and how they relate to development and disease using third generation sequencing of transcriptomes.
Characterization of epigenetic modifications
Another application enabled by long reads is direct detection and phasing of epigenetic modifications along individual DNA molecules. Techniques like single-molecule, real-time (SMRT) sequencing allow detection of modifications like DNA methylation without relying on biochemical enrichment. This facilitates characterization of complex differential methylation patterns, epigenetic variability between cells and correlation with gene regulation. Long read methylome data are improving our understanding of epigenetic mechanisms in health and disease.
Microbial genomics and metagenomics
For complex microbial samples and metagenomic communities, assembly from short reads remains challenging due to limitations in resolving repeats and separating closely related species. Long reads resolve population genomes within samples and reconstruct near-complete genomes for uncultured organisms. This has enabled characterization of human microbiome diversity at an unprecedented resolution. Long read shotgun metagenomics is now revealing microbialDark matter and untangling community dynamics in diverse environments.
Resolving complex structural variations
Structural variations like inversions, translocations and copy number variants have been strongly linked with genetic diseases, yet can be challenging to characterize fully with short reads due to complex breakpoints. The ability of long reads to phase heterozygous structural variants over long genomic distances allows detailed breakpoint mapping. Projects like Genome in a Bottle are leveraging this to establish reference-grade haplotypes including complex variations for medical genomics.
Single-cell applications are on the rise
The ability to analyze DNA or RNA from single cells using nanopore or microfluidic platforms has created great potential for longitudinal studies of development, plasticity and evolution. Early applications include isoform heterogeneity analysis from individual tumor cells, preimplantation embryonic development profiling and tracing cell lineages. As the costs decrease further, long read single-cell sequencing promises to revolutionize our understanding of cellular heterogeneity and dynamics in health and disease.
Technology advancements are expanding applications
Significant progress continues to be made in developing faster, cheaper and more accurate long read sequencing platforms. New chemistries and motors are increasing read lengths on nanopore devices to multiple kilobases routinely. Advancements in template preparation and sequencing chemistry are improving accuracy to over 99% for basecalling. Combining long reads with complementary short read or mapping data yields hybrid assemblies approaching finish-quality standards. These technology advancements are driving down costs to increase adoption across diverse applications in research and molecular diagnostics.
In summary, the ability to generate highly accurate sequencing reads spanning entire genes, transcripts and genomic structural variants is revolutionizing our understanding of genomes, transcriptomes and complex microbial communities. By resolving formerly intractable biological problems, long read sequencing is already transforming fields as diverse as structural variation analysis, single-cell genomics, disease research and clinical diagnosis. With further reductions in cost and improvements in throughput, third generation sequencing platforms are poised to become a mainstay technology that will continue revealing novel insights into health, disease and evolution for years to come.
Expanding capabilities for clinical genetic diagnosis
One area seeing rapid adoption of third generation sequencing is clinical genetic diagnosis and molecular testing. Traditional Sanger sequencing has been the mainstay technology for confirming mutations identified by other methods or elucidating potential disease-causing variants in familial exomes that evade detection. However, Sanger is limited by read length, scalability and turnaround times.
Long read platforms overcome many of these limitations by enabling comprehensive genome or targeted gene panel sequencing from a single test. Multiple laboratories globally have begun validating platforms like the Oxford Nanopore MinION for use in clinical diagnostic workflows. Large contigs generated enable detection of deletions, duplications, mobile element insertions and complex structural variants often missed by other methods. Phased data from linked reads or single-molecule approaches improve specificity by resolving variants in cis configuration.
Applications so far include detection of mutations causing genetic diseases, confirmation of carrier status for recessive conditions, resolving prenatal testing results, establishing diagnoses for rare or complex phenotypes and tumor mutational profiling. Turnaround times of 1-2 days allow for timely patient management decisions. Regulatory approvals and clinical validation studies are ongoing across health systems to establish long read sequencing as a first-line test on par with Sanger sequencing. The ability to query entire pathogenic genes or exomes in a single run stands to revolutionize molecular diagnosis of inherited conditions. Widespread clinical adoption will likely occur over the next 5 years as costs continue declining.
Enabling precision and personalized medicine
By providing nucleotide-level resolution of entire genomes, Disease associated structural variants and epigenomes, long read sequencing technologies are positioned to play a transformative role in precision medicine. Direct phasing of variants, isoforms and haplotypes provides critical information for determining causality, predicting disease risk and understanding individual disease predisposition or drug response. Comprehensive disease gene panels capture multiple types of variation linked to complex inherited disorders.
Pharmacogenomic applications involve analyzing drug metabolism gene regions and linking variant combinations to toxicity risks or efficacy. Genomic counseling leverages phased genomes to resolve carrier status, reproductive risk assessment and predict conditions in future generations with unprecedented resolution. Personal genome sequences analyzed using long reads could guide personalized lifestyle modifications or early disease screening based on unique risk profiles.
Single-cell long read approaches promise to revolutionize tumor evolution models by tracking subclonal architecture and characterizing rare resistant populations. Spatiotemporal genome resolution from formalin-fixed tissues or liquid biopsies may enable noninvasive cancer monitoring and earlier diagnosis. As validation and data standards mature, incorporation of long read generated, phased and structural variant information into precision.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
